Related references
Note: Only part of the references are listed.The opioid and related drug epidemics in rural Appalachia: A systematic review of populations affected, risk factors, and infectious diseases
Christine A. Schalkoff et al.
SUBSTANCE ABUSE (2020)
Promoting treatment for hepatitis C in people who inject drugs: A review of the barriers and opportunities
Annie Pedlar et al.
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (2020)
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
Emma Day et al.
LIVER INTERNATIONAL (2019)
Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated
Meghan D. Morris et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study
Alain H. Litwin et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Staying hepatitis C negative: A systematic review and meta-analysis of cure and reinfection in people who inject drugs
Ned H. Latham et al.
LIVER INTERNATIONAL (2019)
Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison
Hannah Fraser et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2019)
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study
Adam Trickey et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs
Carolina Barbosa et al.
ADDICTION (2019)
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
Thomas F. Baumert et al.
GASTROENTEROLOGY (2019)
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014
Jon E. Zibbell et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
Hepatitis C Virus Diagnosis and the Holy Grail
Tanya L. Applegate et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2018)
Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection
Ulrich Spengler
PHARMACOLOGY & THERAPEUTICS (2018)
A Social-Ecological Review of Cancer Disparities in Kentucky
Sharon D. Rodriguez et al.
SOUTHERN MEDICAL JOURNAL (2018)
The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions
David C. Perlman et al.
CURRENT HIV/AIDS REPORTS (2018)
Access to Syringe Services Programs — Kentucky, North Carolina, and West Virginia, 2013–2017
Danae Bixler et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015
Sumathi Ramachandran et al.
EBIOMEDICINE (2018)
Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016
Eli S. Rosenberg et al.
JAMA NETWORK OPEN (2018)
Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system
Justin C. Strickland et al.
INTERNATIONAL JOURNAL OF PRISONER HEALTH (2018)
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis
Lucy Platt et al.
ADDICTION (2018)
Scaling-up HCV prevention and treatment interventions in rural United Statesmodel projections for tackling an increasing epidemic
Hannah Fraser et al.
ADDICTION (2018)
Elimination of HCV as a public health concern among people who inject drugs by 2030-What will it take to get there?
Jason Grebely et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2017)
Silence Surrounding Hepatitis C Status in Risk Relationships Among Rural People Who Use Drugs
Megan G. Hofmeister et al.
JOURNAL OF PRIMARY PREVENTION (2017)
Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs
Dustin B. Stephens et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection A Systematic Review
Oluwaseun Falade-Nwulia et al.
ANNALS OF INTERNAL MEDICINE (2017)
Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals
Jagpreet Chhatwal et al.
HEPATOLOGY (2016)
County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States
Michelle M. Van Handel et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
Natasha K. Martin et al.
JOURNAL OF HEPATOLOGY (2016)
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
Lucy Platt et al.
LANCET INFECTIOUS DISEASES (2016)
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015
Philip J. Peters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Hepatitis C treatment as prevention: evidence, feasibility, and challenges
Behzad Hajarizadeh et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Confronting the Emerging Epidemic of HCV Infection Among Young Injection Drug Users
Ronald Valdiserri et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2014)
Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals
Natasha K. Martin et al.
HEPATOLOGY (2013)
Epidemiology and natural history of HCV infection
Behzad Hajarizadeh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Network Structure and the Risk for HIV Transmission Among Rural Drug Users
A. M. Young et al.
AIDS AND BEHAVIOR (2013)
Individual and Network Factors Associated With Prevalent Hepatitis C Infection Among Rural Appalachian Injection Drug Users
Jennifer R. Havens et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2012)
Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia
April M. Young et al.
JOURNAL OF MEDICAL VIROLOGY (2012)
Chronic Hepatitis C Infection
Hugo R. Rosen
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
M. Herdman et al.
QUALITY OF LIFE RESEARCH (2011)
Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
Antonio Ascione et al.
GASTROENTEROLOGY (2010)
Sample size determination for logistic regression revisited
Eugene Demidenko
STATISTICS IN MEDICINE (2007)
Initial evidence for the reliability and validity of a Lite version of the Addiction Severity Index
John S. Cacciola et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Projecting future complications of chronic hepatitis C in the United States
GL Davis et al.
LIVER TRANSPLANTATION (2003)
Share Paper
